Exscientia Statistics
Total Valuation
BioVie has a market cap or net worth of $11.18 million. The enterprise value is -$11.60 million.
Important Dates
The next estimated earnings date is Monday, September 29, 2025, after market close.
Earnings Date | Sep 29, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
BioVie has 1.85 million shares outstanding. The number of shares has increased by 199.08% in one year.
Current Share Class | 1.85M |
Shares Outstanding | 1.85M |
Shares Change (YoY) | +199.08% |
Shares Change (QoQ) | +17.75% |
Owned by Insiders (%) | 1.31% |
Owned by Institutions (%) | 5.84% |
Float | 1.83M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 0.51 |
P/TBV Ratio | 0.53 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.32, with a Debt / Equity ratio of 0.02.
Current Ratio | 9.32 |
Quick Ratio | 9.09 |
Debt / Equity | 0.02 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -25.00 |
Financial Efficiency
Return on equity (ROE) is -93.23% and return on invested capital (ROIC) is -48.44%.
Return on Equity (ROE) | -93.23% |
Return on Assets (ROA) | -42.51% |
Return on Invested Capital (ROIC) | -48.44% |
Return on Capital Employed (ROCE) | -86.79% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.38M |
Employee Count | 14 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -84.51% in the last 52 weeks. The beta is 1.07, so BioVie's price volatility has been similar to the market average.
Beta (5Y) | 1.07 |
52-Week Price Change | -84.51% |
50-Day Moving Average | 9.28 |
200-Day Moving Average | 15.92 |
Relative Strength Index (RSI) | 34.02 |
Average Volume (20 Days) | 66,543 |
Short Selling Information
The latest short interest is 152,820, so 8.24% of the outstanding shares have been sold short.
Short Interest | 152,820 |
Short Previous Month | 1.21M |
Short % of Shares Out | 8.24% |
Short % of Float | 8.35% |
Short Ratio (days to cover) | 3.40 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -19.19M |
Pretax Income | -36.29M |
Net Income | -19.36M |
EBITDA | -18.96M |
EBIT | -19.19M |
Earnings Per Share (EPS) | -$16.61 |
Full Income Statement Balance Sheet
The company has $23.15 million in cash and $366,430 in debt, giving a net cash position of $22.79 million or $12.29 per share.
Cash & Cash Equivalents | 23.15M |
Total Debt | 366,430 |
Net Cash | 22.79M |
Net Cash Per Share | $12.29 |
Equity (Book Value) | 21.82M |
Book Value Per Share | 11.78 |
Working Capital | 21.17M |
Full Balance Sheet Cash Flow
Operating Cash Flow | -17.42M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |